Suppr超能文献

急性洋地黄中毒——起搏治疗仍适用吗?

Acute digitalis intoxication--is pacing still appropriate?

作者信息

Taboulet P, Baud F J, Bismuth C, Vicaut E

机构信息

Hopital Fernand Widal, Université Paris VII, France.

出版信息

J Toxicol Clin Toxicol. 1993;31(2):261-73. doi: 10.3109/15563659309000393.

Abstract

Over a six year period, 92 patients intoxicated with either digitoxin or digoxin were admitted to our ICU. Fifty-one patients were treated with cardiac pacing and/or Fab fragments, and the mortality rate was 13% (14 were intoxications with digoxin, 36 with digitoxin, 1 was mixed). Forty-five cases were suicide attempts; six were accidental overdosages. Since cardiac pacing may trigger fatal arrhythmia or delay the administration of Fab fragments, we conducted a retrospective study to determine whether fatal outcomes could be related either to cardiac pacing or to unsatisfactory use of immunotherapy. In our study, prevention of life-threatening arrhythmia failed in 8% of cases with Fab and in 23% with pacing. Though Fab tended to be more effective, this difference was not significant. In our study, the main obstacles to the success of Fab were pacing-induced arrhythmias and delayed or insufficient administration of Fab. Iatrogenic accidents of cardiac pacing were frequent (14/39, 36%) and often fatal (5/39, 13%). In contrast, immunotherapy was not associated with any serious adverse effects (0/28, 0%) and was safer than cardiac pacing (p < 0.05). In conclusion, during digitalis intoxication, the pacemaker has limited preventive and curative effects, is difficult to handle, and exposes patients to severe iatrogenic accidents. Fab fragments act as a powerful antidote and are safer and much easier to use than pacing. These results encourage us to prescribe Fab fragments as first-line therapy during acute digitalis intoxication.

摘要

在六年时间里,92例因洋地黄毒苷或地高辛中毒的患者被收入我们的重症监护病房。51例患者接受了心脏起搏和/或Fab片段治疗,死亡率为13%(14例为地高辛中毒,36例为洋地黄毒苷中毒,1例为混合中毒)。45例为自杀未遂;6例为意外过量用药。由于心脏起搏可能引发致命性心律失常或延迟Fab片段的给药,我们进行了一项回顾性研究,以确定致命结局是否与心脏起搏或免疫治疗使用不当有关。在我们的研究中,Fab治疗组有8%的病例未能预防危及生命的心律失常,起搏治疗组为23%。虽然Fab治疗似乎更有效,但差异不显著。在我们的研究中,Fab治疗成功的主要障碍是起搏诱发的心律失常以及Fab给药延迟或不足。心脏起搏的医源性事故很常见(14/39,36%),且常致命(5/39,13%)。相比之下,免疫治疗未出现任何严重不良反应(0/28,0%),且比心脏起搏更安全(p<0.05)。总之,在洋地黄中毒期间,起搏器的预防和治疗作用有限,操作困难,且会使患者面临严重的医源性事故。Fab片段是一种有效的解毒剂,比起搏更安全、更容易使用。这些结果促使我们在急性洋地黄中毒时将Fab片段作为一线治疗药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验